Previous Article | Next Article 
Journal of Clinical Microbiology, April 2000, p. 1679-1680, Vol. 38, No. 4
Department of Pathology, Section of Molecular
Pathology, University Hospital Vrije Universiteit, Amsterdam, The
Netherlands,1 and Danish Cancer Society,
Institute of Cancer
Epidemiology, Copenhagen,2 and
Defence Medical Training Center,
Gentofte,3 Denmark
Received 18 November 1999/Returned for modification 8 January
2000/Accepted 29 January 2000
Pooling, in groups of five, of urine specimens from
asymptomatically infected men in a population with 4% prevalence, as
determined by case finding, is 100% sensitive and specific and results
in a 60.5% reduction in the number of tests needed. Pooling of urine specimens in groups of 10 for the estimation of population-based prevalence is 96.1% sensitive and 100% specific and saves 90% of the
test costs.
It has been suggested that screening
programs for the detection of asymptomatic Chlamydia
trachomatis infections should be developed to reduce the burden of
disease caused by C. trachomatis (3, 6, 8, 9).
Two studies have been published concerning the pooling of urine
specimens to reduce the costs associated with handling large amounts of
samples for the detection of C. trachomatis (1,
7). The first study (7) used PCR on archived urine
specimens from males, and the second study used ligase chain reaction
(LCR) on fresh urine specimens from women (1); both showed
high test sensitivity and cost-saving aspects. However, while lowering
the cutoff value in the LCR was necessary to identify all positive
pools (1), the first study acknowledged the need to validate
the pooling strategy using fresh urine specimens (7). Members of our group recently showed that PCR performs better than LCR
for the detection of asymptomatic C. trachomatis infections in urine specimens from both males and females (5).
Therefore, this study evaluated different characteristics of urine
specimen pooling for the detection of C. trachomatis by PCR
using fresh urine specimens from asymptomatically infected males in a
low-prevalence population. Two evaluations were performed, as follows:
(i) estimation of the population-based C. trachomatis prevalence without testing C. trachomatis-positive pools and
(ii) identification of all individual C. trachomatis-positive cases based on C. trachomatis-positive pools.
First-voided urine specimens (n = 650) were obtained
from asymptomatic (defined as having no clinical symptoms or not having contacted a physician for possible urogenital complaints) Danish male
military recruits and sent by air mail to the laboratory within 3 days
(samples were at room temperature during transport) (4).
Urine specimens were tested for C. trachomatis by PCR (Amplicor; Roche Diagnostic Systems, Basel, Switzerland). Specimens were tested individually, pooled in groups of five into 130 pools, and
pooled in groups of 10 into 65 pools. Each sample received a laboratory
accession number, and consecutively numbered samples formed each pool.
Specimen preparation and C. trachomatis testing were
performed according to the instructions of the manufacturer and as
described previously (5). For pooled urine specimens the
same procedure for C. trachomatis detection was used except
that, for pools of five urine specimens, instead of 0.5 ml of urine,
five 100-µl samples of urine, well mixed, were used (0.5 ml). For
pools of 10 urine specimens, 10 50-µl samples were used. For both
individual and pooled sample testing, the visibility of the urine
pellet after centrifugation was monitored. Cost analysis was based on the number of tests saved by comparing individual sample testing and
pooling of urine specimens by 5 or by 10, including retesting of the
individual urine samples of the C. trachomatis-positive pools. The estimation of the population-based C. trachomatis
prevalence (maximum likely prevalence [p] was performed as
described previously by Kline et al. (2).
Estimation of the population-based prevalence.
Of the 650 first-voided urine specimens, 26 (4%) were positive for C. trachomatis by PCR, and results were confirmed by retesting. Assessment of the C. trachomatis prevalence in a population
is a prerequisite for cost-benefit analysis to determine if screening in a certain population should be initiated. When urine specimens were
pooled by 5 and by 10, 25 out of 130 pools and 23 out of 65 pools were
C. trachomatis positive, respectively. In both pooling strategies, two pools (containing four different C. trachomatis-positive samples) were grey zone (between 0.2 and 0.8)
and by retesting were C. trachomatis positive and grey zone,
respectively. Both were considered C. trachomatis positive
as defined by the manufacturer's instructions. The population-based
C. trachomatis prevalence could be estimated without testing
all C. trachomatis-positive pools for the individual
C. trachomatis-positive samples. As shown in Table
1, p was 4.2% (95%
confidence interval [CI], 2.54 to 5.82) when urine specimens were
pooled by 5 and 4.3% (95% CI, 2.51 to 6.03) when urine specimens were
pooled by 10. The C. trachomatis prevalence as determined by
individual testing was 4.0%, which is within the 95% CIs of the
estimates of C. trachomatis prevalence. Pooling of urine
specimens by 5 or 10 reduced test costs by 80% (132 versus 650) or
90% (67 versus 650), respectively. These data indicate that pooling by
10, although resulting in a sensitivity of slightly less than 100%,
could be used to determine the C. trachomatis prevalence in
large populations in a strategy that is quick and cost saving compared
to individual sample testing.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Pooling of Urine Specimens for Detection of
Asymptomatic Chlamydia trachomatis Infections by PCR in a
Low-Prevalence Population: Cost-Saving Strategy for Epidemiological
Studies and Screening Programs
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
TABLE 1.
Data for urine specimens collected and pooled for the
detection of C. trachomatis in an asymptomatically infected
male population
Case finding based on C. trachomatis-positive pools. When urine specimens were pooled by 5, individual testing showed that 24 pools contained one C. trachomatis-positive case each and 1 pool contained two C. trachomatis-positive cases, adding up to the identification of all 26 C. trachomatis-positive males. This makes the pooling of urine specimens by 5 100% sensitive and 100% specific (Table 1). When urine specimens were pooled by 10, individual testing showed that 22 pools contained one C. trachomatis-positive case each and 1 pool contained three C. trachomatis-positive cases, adding up to the identification of 25 of the 26 C. trachomatis-positive males. This makes the pooling of urine specimens by 10 96.1% sensitive and 100% specific (Table 1). Peeling et al. (7) showed that pooling by five of archival male urine specimens was 94.4% sensitive as determined by PCR. Kacena et al. (1) showed that pooling urine specimens from females by 4 was 100% sensitive, while pooling by 10 was 98.4% sensitive as determined by LCx.
By pooling 5 or 10 urine specimens, 60.5% (257 versus 650) and 54% (297 versus 650) of the test costs were saved, respectively. Peeling et al. (7) showed that five-specimen pooling resulted in a cost savings of 57%. Kacena et al. (1) included test price (LCx), technician time, laboratory consumables, and the C. trachomatis prevalence (4%) in the cost analysis and showed that pooling specimens in groups of 5 would result in a 49% cost savings. When we included these additional variables in our setting, the total cost savings of a five-specimen pooling strategy was 61.9% compared to individual testing. These data show that case finding by pooling five urine specimens in this population with a C. trachomatis prevalence of 4% is a sensitive and cost-saving approach. Besides the cost-saving aspects, two additional favorable effects of pooling urine specimens were observed. Of the urine specimens tested individually, 12.5% (81 out of 650) had an invisible pellet after centrifugation of a 0.5-ml urine specimen plus 0.5 ml of wash buffer. This made correct removal of the supernatant difficult. Furthermore, three urine samples showed inhibition, as determined by the inability to amplify the internal control included in the Amplicor assay. This corresponds to an inhibition rate of 0.5%. In contrast, all pooled urine specimens, whether pooled by 5 or by 10, had a visible pellet after centrifugation (P < 0.0001, versus individual testing), which made the removal of the supernatant easier. Furthermore, no inhibition was observed in the pooled urine specimens. This decrease of inhibition was probably due to dilution of the inhibitory factors. However, when urine specimens were tested individually, pooled by 5, and pooled by 10, the number of grey-zone values for the C. trachomatis-positive pools increased from 0% (0 of 650) to 1.5% (2 of 130) and 3% (2 of 65), respectively. However, it was not necessary to change the sample cutoff value for the pooled specimens, a change that Kacena et al. (1) found to be necessary for the LCR, and five-specimen pooling was still 100% sensitive. Two possible disadvantages should be acknowledged. Although urine specimens stay stable up to 1 week at room temperature (4), special laboratory logistics are needed to test all individual samples in the C. trachomatis-positive pools within 1 week. Alternatively, urine specimens could be stored at 4°C. Secondly, the pooling strategy might encounter the difficulty of being "off label" in some areas. Most likely, governmental screening programs will be able to use the pooling strategy, but obtaining approval for specific diagnostic screening programs could be difficult. In conclusion, this study showed that the implementation of the pooling strategy for urine specimens for the detection of C. trachomatis could have a major impact on the feasibility of screening programs.| |
ACKNOWLEDGMENTS |
|---|
This work was partly supported by grants 28-1182-1 and 28-2705 from ZON (Prevention Fund), Amsterdam, The Netherlands.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Pathology, Section of Molecular Pathology, University Hospital Vrije Universiteit, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. Phone: 31-20-4440503 or 44023. Fax: 31-20-4442964. E-mail: vandenbrule{at}azvu.nl.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. |
Kacena, K. A.,
S. B. Quinn,
M. R. Howell,
G. E. Madico,
T. C. Quinn, and C. A. Gaydos.
1998.
Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women.
J. Clin. Microbiol.
36:481-485 |
| 2. |
Kline, R. L.,
T. A. Brothers,
R. Brookmeyer,
S. Zeger, and T. C. Quinn.
1989.
Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera.
J. Clin. Microbiol.
27:1449-1452 |
| 3. |
Lan, J.,
A. J. C. Van den Brule,
D. J. Hemrika,
E. K. J. Risse,
J. M. M. Walboomers,
M. E. I. Schipper, and C. J. L. M. Meijer.
1995.
Chlamydia trachomatis and ectopic pregnancy: retrospective analysis of salpingectomy specimens, endometrial biopsies and cervical smears.
J. Clin. Pathol.
48:815-819 |
| 4. |
Morré, S. A.,
I. G. M. van Valkengoed,
A. de Jong,
A. J. P. Boeke,
J. T. M. van Eijk,
C. J. L. M. Meijer, and A. J. C. van den Brule.
1999.
Mailed, home-obtained urine specimens: a reliable screening approach for asymptomatic Chlamydia trachomatis infections.
J. Clin. Microbiol.
37:976-980 |
| 5. |
Morré, S. A.,
I. G. M. Van Valkengoed,
R. M. Moes,
A. J. P. Boeke,
C. J. L. M. Meijer, and A. J. C. Van den Brule.
1999.
Determination of the Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of LCx and COBAS Amplicor tests in urine specimens.
J. Clin. Microbiol.
37:3092-3096 |
| 6. | Mosure, D. J., S. Berman, D. Fine, S. Delisle, W. Cates, Jr., and J. R. Boring, III. 1997. Genital chlamydia infections in sexually active adolescents: do we really need to screen everyone? J. Adolesc. Health 20:6-13[CrossRef][Medline]. |
| 7. | Peeling, R. W., B. Toye, P. Jessamine, and I. Gemmill. 1998. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex. Transm. Infect. 74:66-70[Abstract]. |
| 8. |
Scholes, D.,
A. Stergachis,
F. E. Heidrich,
H. Andrilla,
K. K. Holmes, and W. E. Stamm.
1996.
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infections.
N. Engl. J. Med.
334:1362-1366 |
| 9. |
Stamm, W. E.
1998.
Expanding efforts to prevent chlamydial infection.
N. Engl. J. Med.
339:768-769 |
Journal of Clinical Microbiology, April 2000, p. 1679-1680, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mahilum-Tapay, L., Laitila, V., Wawrzyniak, J. J, Lee, H. H, Alexander, S., Ison, C., Swain, A., Barber, P., Ushiro-Lumb, I., Goh, B. T
(2007). New point of care Chlamydia Rapid Test bridging the gap between diagnosis and treatment: performance evaluation study. BMJ
335: 1190-1194
[Abstract] [Full Text] -
Whiley, D. M., Tapsall, J. W., Sloots, T. P.
(2006). Nucleic Acid Amplification Testing for Neisseria gonorrhoeae: An Ongoing Challenge. J. Mol. Diagn.
8: 3-15
[Abstract] [Full Text] -
Lindan, C., Mathur, M., Kumta, S., Jerajani, H., Gogate, A., Schachter, J., Moncada, J.
(2005). Utility of Pooled Urine Specimens for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Men Attending Public Sexually Transmitted Infection Clinics in Mumbai, India, by PCR. J. Clin. Microbiol.
43: 1674-1677
[Abstract] [Full Text] -
van Bergen, J, Gotz, H M, Richardus, J H, Hoebe, C J P A, Broer, J, Coenen, A J T, for the PILOT CT study group,
(2005). Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex. Transm. Infect.
81: 17-23
[Abstract] [Full Text] -
Currie, M. J., McNiven, M., Yee, T., Schiemer, U., Bowden, F. J.
(2004). Pooling of Clinical Specimens Prior to Testing for Chlamydia trachomatis by PCR Is Accurate and Cost Saving. J. Clin. Microbiol.
42: 4866-4867
[Abstract] [Full Text] -
Melese, M., Chidambaram, J. D., Alemayehu, W., Lee, D. C., Yi, E. H., Cevallos, V., Zhou, Z., Donnellan, C., Saidel, M., Whitcher, J. P., Gaynor, B. D., Lietman, T. M.
(2004). Feasibility of Eliminating Ocular Chlamydia trachomatis With Repeat Mass Antibiotic Treatments. JAMA
292: 721-725
[Abstract] [Full Text] -
Klavs, I, Rodrigues, L C, Wellings, K, Kese, D, Hayes, R
(2004). Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control. Sex. Transm. Infect.
80: 121-123
[Abstract] [Full Text] -
Kissin, D M, Holman, S, Minkoff, H L, DeMeo, L, McCormack, W M, DeHovitz, J A
(2002). Epidemiology and natural history of ligase chain reaction detected chlamydial and gonococcal infections. Sex. Transm. Infect.
78: 208-209
[Abstract] [Full Text] -
Morre, S A, Welte, R, Postma, M J
(2002). Major improvements in cost effectiveness of screening women for Chlamydia trachomatis using pooled urine specimens and high performance testing. Sex. Transm. Infect.
78: 74-75
[Full Text] -
Gomes, J P, Ferreira, M A, de Sa, A B., Catry, M A
(2001). Pooling urine samples for PCR screening of C trachomatis urogenital infection in women. Sex. Transm. Infect.
77
: 76-77
[Full Text] -
Drancourt, M., Bollet, C., Carlioz, A., Martelin, R., Gayral, J.-P., Raoult, D.
(2000). 16S Ribosomal DNA Sequence Analysis of a Large Collection of Environmental and Clinical Unidentifiable Bacterial Isolates. J. Clin. Microbiol.
38: 3623-3630
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»